Loading…

Effect of statins in preventing hospitalizations for infections: A population study

Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population l...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacoepidemiology and drug safety 2018-08, Vol.27 (8), p.878-884
Main Authors: Policardo, Laura, Seghieri, Giuseppe, Gualdani, Elisa, Franconi, Flavia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43
cites cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43
container_end_page 884
container_issue 8
container_start_page 878
container_title Pharmacoepidemiology and drug safety
container_volume 27
creator Policardo, Laura
Seghieri, Giuseppe
Gualdani, Elisa
Franconi, Flavia
description Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines. Results Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54. Conclusions Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).
doi_str_mv 10.1002/pds.4557
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2046606503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2046606503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk7BXyAFb7yppknTNN4NnR8wUJheh6xJtKNratIq89d7uk0Fwauc8D55yHkROk7weYIxuWh0OE8Z4ztomGAh4gTm3X5mNM5ZJgboIIQFxpCJdB8NiMhxzjAdotnEWlO0kbNRaFVb1iEq66jx5t3UcHuJXl1oylZV5SekDmLrPCD9o_56GY2jxjVdtU7B0enVIdqzqgrmaHuO0PPN5OnqLp4-3N5fjadxQVPBY8GLwgiSFRTbOSNcMZ4xTjijiTGZMjlPBcFWM2a00oxQzfOcaApbAaJSOkJnG2_j3VtnQiuXZShMVanauC5IgtMswxnsCejpH3ThOl_D74DKE0EFT_mvsPAuBG-sbHy5VH4lEyz7oiUULfuiAT3ZCrv50ugf8LtZAOIN8FFWZvWvSD5ez9bCLw1BhjE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2081939747</pqid></control><display><type>article</type><title>Effect of statins in preventing hospitalizations for infections: A population study</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</creator><creatorcontrib>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</creatorcontrib><description>Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines. Results Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54. Conclusions Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</description><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.4557</identifier><identifier>PMID: 29808503</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Bacterial infections ; Diabetes mellitus ; Health risks ; hospitalizations ; Infections ; Infectious diseases ; Ischemia ; number needed to treat ; pharmacoepidemiology ; Population ; Population studies ; population study ; propensity score ; Statins</subject><ispartof>Pharmacoepidemiology and drug safety, 2018-08, Vol.27 (8), p.878-884</ispartof><rights>Copyright © 2018 John Wiley &amp; Sons, Ltd.</rights><rights>2018 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</citedby><cites>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</cites><orcidid>0000-0002-7599-4455</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29808503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Policardo, Laura</creatorcontrib><creatorcontrib>Seghieri, Giuseppe</creatorcontrib><creatorcontrib>Gualdani, Elisa</creatorcontrib><creatorcontrib>Franconi, Flavia</creatorcontrib><title>Effect of statins in preventing hospitalizations for infections: A population study</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><description>Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines. Results Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54. Conclusions Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</description><subject>Bacterial infections</subject><subject>Diabetes mellitus</subject><subject>Health risks</subject><subject>hospitalizations</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Ischemia</subject><subject>number needed to treat</subject><subject>pharmacoepidemiology</subject><subject>Population</subject><subject>Population studies</subject><subject>population study</subject><subject>propensity score</subject><subject>Statins</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kF1LwzAUhoMobk7BXyAFb7yppknTNN4NnR8wUJheh6xJtKNratIq89d7uk0Fwauc8D55yHkROk7weYIxuWh0OE8Z4ztomGAh4gTm3X5mNM5ZJgboIIQFxpCJdB8NiMhxzjAdotnEWlO0kbNRaFVb1iEq66jx5t3UcHuJXl1oylZV5SekDmLrPCD9o_56GY2jxjVdtU7B0enVIdqzqgrmaHuO0PPN5OnqLp4-3N5fjadxQVPBY8GLwgiSFRTbOSNcMZ4xTjijiTGZMjlPBcFWM2a00oxQzfOcaApbAaJSOkJnG2_j3VtnQiuXZShMVanauC5IgtMswxnsCejpH3ThOl_D74DKE0EFT_mvsPAuBG-sbHy5VH4lEyz7oiUULfuiAT3ZCrv50ugf8LtZAOIN8FFWZvWvSD5ez9bCLw1BhjE</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Policardo, Laura</creator><creator>Seghieri, Giuseppe</creator><creator>Gualdani, Elisa</creator><creator>Franconi, Flavia</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7599-4455</orcidid></search><sort><creationdate>201808</creationdate><title>Effect of statins in preventing hospitalizations for infections: A population study</title><author>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bacterial infections</topic><topic>Diabetes mellitus</topic><topic>Health risks</topic><topic>hospitalizations</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Ischemia</topic><topic>number needed to treat</topic><topic>pharmacoepidemiology</topic><topic>Population</topic><topic>Population studies</topic><topic>population study</topic><topic>propensity score</topic><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Policardo, Laura</creatorcontrib><creatorcontrib>Seghieri, Giuseppe</creatorcontrib><creatorcontrib>Gualdani, Elisa</creatorcontrib><creatorcontrib>Franconi, Flavia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Policardo, Laura</au><au>Seghieri, Giuseppe</au><au>Gualdani, Elisa</au><au>Franconi, Flavia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of statins in preventing hospitalizations for infections: A population study</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2018-08</date><risdate>2018</risdate><volume>27</volume><issue>8</issue><spage>878</spage><epage>884</epage><pages>878-884</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><abstract>Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines. Results Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54. Conclusions Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29808503</pmid><doi>10.1002/pds.4557</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7599-4455</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1053-8569
ispartof Pharmacoepidemiology and drug safety, 2018-08, Vol.27 (8), p.878-884
issn 1053-8569
1099-1557
language eng
recordid cdi_proquest_miscellaneous_2046606503
source Wiley-Blackwell Read & Publish Collection
subjects Bacterial infections
Diabetes mellitus
Health risks
hospitalizations
Infections
Infectious diseases
Ischemia
number needed to treat
pharmacoepidemiology
Population
Population studies
population study
propensity score
Statins
title Effect of statins in preventing hospitalizations for infections: A population study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20statins%20in%20preventing%20hospitalizations%20for%20infections:%20A%20population%20study&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Policardo,%20Laura&rft.date=2018-08&rft.volume=27&rft.issue=8&rft.spage=878&rft.epage=884&rft.pages=878-884&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.4557&rft_dat=%3Cproquest_cross%3E2046606503%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2081939747&rft_id=info:pmid/29808503&rfr_iscdi=true